跳至主要内容
临床试验/NCT00995683
NCT00995683已完成2 期

Effect of Preventive Sodium Lactate Infusion on Intracranial Hypertension in Severe Trauma Tic Brain Injury

Institut d'Anesthesiologie des Alpes Maritimes1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2009年6月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
60
试验地点
1
主要终点
the number of treatments required for intracranial hypertensive episodes during the first 48 hours following ICU admission

研究概览

简要总结

The goal of this study is to evaluate the effect of preventive intravenous infusion of half molar sodium lactate on the onset of hypertensive intracranial episodes in severe head trauma. The investigators hypothesize that preventive intravenous administration of sodium lactate will decrease the number of treatments required to decrease intracranial pressure during 48 hours.

详细描述

  • Intracranial hypertension is the most severe complication of severe head injury. This may lead to cerebral death or severe neurological outcome. To improve the prognosis of these patients,intracranial pressure must be maintained in normal range while maintaining cerebral perfusion pressure. Among numerous strategies, osmotherapy is frequently proposed to decrease intracranial pressure, using mannitol or hypertonic saline. Recently, it has been found that hypertonic sodium lactate infusion is more efficient to decrease intracranial hypertension compared with an equivalent volemic and osmotic mannitol administration.Thus, we hypothesized that a preventive sodium lactate infusion in severe head trauma could decrease the number of intracranial hypertensive episodes.
  • Methods and Objectives : to compare in a randomized double-blind fashion two group of patients, i.e., those receiving a standard isotonic saline infusion (control group) with those receiving half-molar sodium lactate for 48 hours following admission in ICU. The primary endpoint is the number of any treatment required to control intracranial hypertensive episodes occurring during the first 48 hours following admission in ICU. Secondary endpoints are the effect of sodium lactate infusion on : intracranial pressure evolution;neurological outcome at 6 months (glasgow outcome scale); cerebral blood flow evaluated by transcranial doppler; and daily water balance
  • Protocol consisted to measure as soon as possible baseline intracranial pressure and cerebral perfusion pressure, then immediately to begin the administration of 0.5 ml/kg/h intravenous isotonic saline perfusion or half-molar sodium lactate during 48 hours in a randomized double-blind fashion. Management of patients is the same for all patients. Treatment required for intracranial hypertensive episode is decided by a senior physician in charge of the patient. Sample size has been calculated considering that 50% of these patients will develop at least one intracranial hypertensive episode, each of them requiring at least 2 treatments. Based on previous results, we hypothesized that sodium lactate will decrease the number of required treatment by 2, leading to a sample size of 30 patients per group
  • Follow up : 48 hours for treatments of intracranial hypertensive episodes; 6 months for the neurological outcome (glasgow outcome scale)

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • severe head trauma with a glasgow coma scale less than 9

排除标准

  • prehospital cardiac arrest
  • severe hemorrhage shock
  • severe circulatory or respiratory failure
  • medullar trauma
  • prehospital osmotherapy

研究组 & 干预措施

half sodium lactate

Experimental

infusion of 0.5 ml/kg/day during 48 hours

干预措施: half molar sodium lactate (Drug)

isotonic sodium chloride

Active Comparator

infusion of 0.5 ml/kg during 48 hours

干预措施: isotonic sodium chloride (Drug)

结局指标

主要结局

the number of treatments required for intracranial hypertensive episodes during the first 48 hours following ICU admission

时间窗: 48 hours

次要结局

  • the neurological outcome at six months evaluated by the glasgow outcome scale(6 months)

研究者

发起方
Institut d'Anesthesiologie des Alpes Maritimes
申办方类型
Other

研究点 (1)

Loading locations...

相似试验